Disclaimer: All stock information on i3capital.com is currently being fed from multiple sources and is updated automatically every 10-minutes. The information on this site is for information purposes only and i3 capital is neither responsible nor liable for the accuracy of this data

TSXV:VVTM

VVT Med, Inc. develops, manufactures, and commercializes minimally invasive, non-thermal, and non-tumescent solutions for the treatment of varicose veins. Its product portfolio includes ScleroSafe and V-Block, which offer several competitive advantages over traditional treatments, such as shorter procedure times, reduced patient discomfort without the need for anesthesia, and faster recovery and visible results. The company was founded in 1969 and is headquartered in Vancouver, Canada.